Yorioka N - Search Results

1

Efficacy of a disease management program focused on acquisition of self-management skills in pre-dialysis patients with diabetic nephropathy: 24 months follow-up.

Kazawa K, Takeshita Y, Yorioka N, Moriyama M. Kazawa K, et al. Among authors: yorioka n. J Nephrol. 2015 Jun;28(3):329-38. doi: 10.1007/s40620-014-0144-2. Epub 2014 Sep 24. J Nephrol. 2015. PMID: 25249468 Clinical Trial.

2

An oral adsorbent, AST-120, combined with a low-protein diet and RAS blocker, for chronic kidney disease.

Yorioka N, Kiribayashi K, Naito T, Ogata S, Yokoyama Y, Kyuden Y, Ogawa T, Wada K, Hayashi K, Hirabayashi A. Yorioka N, et al. J Nephrol. 2008 Mar-Apr;21(2):213-20. J Nephrol. 2008. PMID: 18446716 Clinical Trial.

3

Renal histology before and after effective enzyme replacement therapy in a patient with classical Fabry's disease.

Hirashio S, Taguchi T, Naito T, Maki K, Ogata S, Taniyama K, Taniguchi Y, Yorioka N. Hirashio S, et al. Among authors: yorioka n. Clin Nephrol. 2009 May;71(5):550-6. doi: 10.5414/cnp71550. Clin Nephrol. 2009. PMID: 19473616

4

Effects of icodextrin on glycemic and lipid profiles in diabetic patients undergoing peritoneal dialysis.

Babazono T, Nakamoto H, Kasai K, Kuriyama S, Sugimoto T, Nakayama M, Hamada C, Furuya R, Hasegawa H, Kasahara M, Moriishi M, Tomo T, Miyazaki M, Sato M, Yorioka N, Kawaguchi Y; Japanese Extraneal Collaborated Study Group. Babazono T, et al. Among authors: yorioka n. Am J Nephrol. 2007;27(4):409-15. doi: 10.1159/000105123. Epub 2007 Jul 3. Am J Nephrol. 2007. PMID: 17622748 Clinical Trial.

5

Peritoneal damage by peritoneal dialysis solutions.

Ito T, Yorioka N. Ito T, et al. Among authors: yorioka n. Clin Exp Nephrol. 2008 Aug;12(4):243-249. doi: 10.1007/s10157-008-0032-y. Epub 2008 Feb 15. Clin Exp Nephrol. 2008. PMID: 18274701 Review.

6

Environmental factors influencing the survival of chronic dialysis patients.

Ogata S, Yorioka N. Ogata S, et al. Among authors: yorioka n. Clin Exp Nephrol. 2011 Jun;15(3):405-409. doi: 10.1007/s10157-010-0400-2. Epub 2011 Jan 20. Clin Exp Nephrol. 2011. PMID: 21249416

7

A new peritoneal dialysis fluid for Japanese patients: a randomized non-inferiority clinical trial of safety and efficacy.

Nakayama M, Kawaguchi Y, Akiba T, Kim M, Naito H, Hara S, Maeba T, Yorioka N, Sloand JA, Marshall MR. Nakayama M, et al. Among authors: yorioka n. Clin Exp Nephrol. 2017 Oct;21(5):895-907. doi: 10.1007/s10157-016-1346-9. Epub 2016 Oct 25. Clin Exp Nephrol. 2017. PMID: 27783275 Free PMC article. Clinical Trial.

8

Morning blood pressure is useful for detection of left ventricular hypertrophy in hemodialysis patients.

Ago R, Nakashima A, Naito T, Doi S, Ochiai M, Hamaguchi N, Yokoyama Y, Tanaka J, Yorioka N, Masaki T, Kohno N. Ago R, et al. Among authors: yorioka n. Clin Exp Nephrol. 2012 Dec;16(6):921-9. doi: 10.1007/s10157-012-0639-x. Epub 2012 May 12. Clin Exp Nephrol. 2012. PMID: 22581063

9

Localization of hepatocyte growth factor and tubulointerstitial lesions in IgA nephropathy.

Taniguchi Y, Yorioka N, Yamashita K, Xue-Feng Y, Nishiki T, Ogawa T, Oda H, Yamakido M. Taniguchi Y, et al. Among authors: yorioka n. Am J Nephrol. 1997;17(5):413-6. doi: 10.1159/000169132. Am J Nephrol. 1997. PMID: 9382157

10

Clinicopathological study of myeloperoxidase anti-neutrophil cytoplasmic antibody-associated glomerulonephritis.

Yorioka N, Taniguchi Y, Amimoto D, Ogata S, Sakikubo E, Yamakido M, Naito T, Shimamoto F. Yorioka N, et al. Clin Nephrol. 1999 Nov;52(5):293-6. Clin Nephrol. 1999. PMID: 10584992

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

219 results

Search Page